In inhalation therapy, drugs are deposited as aerosols onto the air-facing lung epithelium. The currently used in vitro cell assays for drug testing, however, typically dissolve drugs in the medium completely covering the cells which represents an unphysiological drug application scenario. While physiologically realistic in vitro cell culture models of the pulmonary air-blood barrier are available, reliable, easy-to-handle and efficient technologies for direct aerosol-to-cell delivery are lacking. Here, we introduce the ALICE-CLOUD technology, which utilizes principles of cloud motion for fast and quantitative delivery of aerosolized liquid drugs to pulmonary cells cultured under realistic air-liquid interface conditions. Aerosol-to-cell delivery proved to be highly efficient, reproducible and rapid when using aerosolized fluorescein as surrogate drug. As a proof-of-concept study for the ALICE-
